WeTrials
Recruiting

A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial

What is this study?

This study is testing a special way to deliver chemotherapy directly to the liver using a small pump, alongside standard chemotherapy. Doctors want to see if this targeted approach works better at shrinking liver tumors from colon or rectum cancer than standard chemotherapy alone.

Who can participate?

You may be able to join if you are 18 or older and have colon or rectum cancer that has spread to the liver and cannot be removed by surgery. The cancer should mostly be in the liver, though very small, stable lung spots may be allowed.

What will happen?

Participants will be randomly assigned to receive either standard chemotherapy alone or standard chemotherapy combined with a pump that delivers medicine straight into the liver. You will also have regular check-ups, imaging scans, and safety monitoring throughout the study.

Where and when?

This study is currently recruiting patients at medical centers in locations including Alabama and Arizona. Your care team will let you know if a participating hospital is convenient for you.

Key Points
  • 1Tests direct chemotherapy delivery to liver tumors using a specialized pump.
  • 2Compares pump treatment plus standard care against standard care alone.
  • 3Currently recruiting participants at select hospitals in the United States.

Related video

PUMP trial study chair Dr. Michael Lidsky on the liver pump chemotherapy study (2024)

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8Unresectable Colorectal Carcinoma

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.